Anti-Disinformation Messaging for Menthol Cigarette Addiction

SC
Overseen ByStudy Coordinator
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Rutgers, The State University of New Jersey
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how tailored anti-disinformation messages, a communication strategy, can influence views on menthol cigarette and flavored cigar policies among Black adults. The study tests different approaches to assess their effectiveness in changing opinions and potentially reducing smoking rates. Participants will join either an individual or community-level messaging group, or both, to measure the impact. Adults living in Atlanta, GA, or Birmingham, AL, who can engage in online activities over a year, are well-suited for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative strategies that may shape future public health policies.

Do I have to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this anti-disinformation messaging is safe?

Research has shown that campaigns similar to the one under study have been used to address false information about menthol tobacco products. These efforts have included media campaigns, such as a statewide initiative aimed at raising awareness in Black communities about menthol tobacco. Reports suggest these campaigns have been generally well-received and have reached a significant number of people.

Since this study focuses on messaging and communication strategies, not on a drug or medical device, typical safety concerns like side effects do not apply. The main goal is to assess how effectively the information is shared and whether it successfully corrects misinformation. Previous studies have not reported any negative effects from the messaging itself. Participants in similar studies have not experienced harm or negative effects from receiving these messages.

For those considering participation, the study mainly involves interacting with information and possibly providing feedback on its impact, with no known risks to health.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores anti-disinformation messaging as a novel approach to combat menthol cigarette addiction. Unlike traditional methods that often focus on behavioral therapy or nicotine replacement, this trial aims to tackle misinformation at both the individual and community levels. By addressing the false beliefs and myths surrounding menthol cigarettes, the trial hopes to reduce smoking rates more effectively. This innovative strategy could pave the way for new public health interventions that are more aligned with tackling the root causes of addiction.

What evidence suggests that anti-disinformation messaging is effective for menthol cigarette addiction?

Research has shown that false information about menthol cigarettes can influence smoking behavior. A study examining Twitter posts found many false claims, such as the notion that menthol cigarettes are safe. Correcting these myths might change perceptions and reduce smoking rates. This trial will test various anti-disinformation messaging strategies. One arm will combine individual-level interventions with community-level interventions, while another will focus on individual-level interventions with community-level control. An earlier study on media campaigns found that clear messages can encourage smoking cessation. These findings suggest that messages countering false information could help people quit smoking, particularly those who use menthol cigarettes.12367

Who Is on the Research Team?

AC

Andrea C Villanti, PhD, MPH

Principal Investigator

Rutgers University

KL

Kymberle L Sterling, DrPH

Principal Investigator

Rutgers University

Are You a Good Fit for This Trial?

This trial is for Black or African American adults, age 18 or older, who live in Atlanta, GA or Birmingham, AL. Participants must be able to read and speak English and be willing to complete online surveys over a year.

Inclusion Criteria

Willing to engage in all online study activities including online quarterly surveys over a 12-month period.
African American or Black adults
I am 18 years old or older.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Survey

Participants complete the baseline survey providing sociodemographic information and baseline measures of study outcomes

1 week

Intervention

Participants receive the ADM intervention or control condition, with follow-up assessments at 3, 6, 9, and 12 months

12 months
4 follow-up assessments (3, 6, 9, 12 months)

Community-level Intervention

Community partners in Atlanta disseminate ADM intervention messages through community networks for 12 months

12 months

Follow-up

Participants are monitored for changes in beliefs and knowledge about tobacco industry and policies

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Anti-disinformation Messaging

Trial Overview

The study is testing two ways of delivering messages that correct false information about menthol cigarettes and flavored cigars: one-on-one (individual) delivery versus community-wide delivery.

How Is the Trial Designed?

4

Treatment groups

Experimental Treatment

Active Control

Group I: Individual-level intervention + Community-level interventionExperimental Treatment2 Interventions
Group II: Individual-level intervention + Community-level controlExperimental Treatment1 Intervention
Group III: Individual-level control + Community-level interventionExperimental Treatment1 Intervention
Group IV: Individual-level control + Community-level controlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials
471
Recruited
81,700+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Citations

Project Details

The proposed study seeks to develop and evaluate the effectiveness of multi-level, anti-disinformation messages (ADM) to disrupt the spread and mitigate the ...

It's Not Just: Evaluation of a Media Campaign to Motivate ...

Evaluating the impact of menthol cigarette bans on cessation and smoking behaviours in Canada: longitudinal findings from the Canadian arm ...

An Analysis of Twitter Posts About the U.S. Food and Drug ...

Similar to previous Twitter analyses, our data contained misinformation (eg, that menthol smoking prevents against disease, that tobacco and menthol are safe ...

Correcting Disinformation About Menthol Cigarettes and ...

Our study tests a multi-level anti- disinformation message (ADM) campaign on menthol cigarette and flavored cigar policies in Black adults.

Menthol cigarettes and smoking cessation behavior

Although some studies have found that menthol smokers have less success in quitting smoking, others fail to find significant differences between menthol and non ...

PERSPECTIVE - Banning Menthol Cigarette Manufacture ...

A looming query is the following: What should the lung health workforce do to support the FDA. Rule on Menthol? First, strategize to fight misinformation.

Tobacco control policies discussed on social media - The BMJ

Such data can also identify misinformation that can be addressed during messaging campaigns or methods used to circumvent the law, which can inform and ...